Drug manufacturers may need to study 7,000 people in order to show a barely statistically significant 15% drop in ischemic events in a subsample of patients, whereas Esselstyn got a 100% drop in those who stuck to his diet, all the more compelling considering that those 18 participants experienced 49 coronary events, meaning like heart attacks, in the eight years before they went on the diet.